Defining a new threshold for PSA outcomes in untreated prostate cancer.

被引：0
|
作者：
Beekman, KW [1 ]
Wilton, A [1 ]
Heller, G [1 ]
Bianco, FJ [1 ]
Lilja, H [1 ]
Slovin, S [1 ]
Scardino, PT [1 ]
Scher, HI [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4587
引用
收藏
页码：403S / 403S
页数：1
相关论文
共 50 条
  • [31] PSA velocity threshold for predicting prostate cancer in young men with PSA < 4 ng/ml
    Loeb, S
    Roehl, KA
    Graif, T
    Viprakasit, D
    Catalona, WJ
    Nadler, RB
    JOURNAL OF UROLOGY, 2006, 175 (04): : 153 - 153
  • [32] Immune impact induced by PSA-tricom, a therapeutic vaccine for prostate cancer.
    Madan, Ravi Amrit
    Tsang, Kwong Yok
    Jochems, Caroline
    Marte, Jennifer L.
    Tucker, Jo A.
    Hodge, James W.
    Singh, Harpreet
    Surolia, Ira
    Coyne, Geraldine Helen O'Sullivan
    Liewehr, David J.
    Steinberg, Seth M.
    Heery, Christopher Ryan
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [33] We Need a Better Marker for Prostate Cancer. How About Renaming PSA?
    Vickers, Andrew J.
    Lilja, Hans
    UROLOGY, 2012, 79 (02) : 254 - 255
  • [34] General practitioners' reflections on using PSA for diagnosis of prostate cancer. A qualitative study
    Thorsen, Olav
    Viste, Eirik
    Lid, Torgeir Gilje
    Kjosavik, Svein R.
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2022, 40 (01) : 123 - 128
  • [35] Detection of circulating prostatic cells by PSA RT-PCR in prostate cancer.
    de la Taille, A
    Salomon, L
    Colombel, M
    Abbou, CC
    Chopin, D
    Groux-Muscatelli, B
    PROGRES EN UROLOGIE, 1999, 9 (06): : 1084 - 1089
  • [36] Natural history of rising serum PSA in men with castrate nonmetastatic prostate cancer.
    Smith, MR
    Kabbinavar, F
    Saad, F
    Hussain, A
    Hei, YJ
    Small, E
    Cook, R
    Higano, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 381S - 381S
  • [37] Characterization of PSA at death in patients with metastatic castration-resistant prostate cancer.
    Bikkasani, Krishna
    Qin, Qian
    Lin, Justin
    Galsky, Matt D.
    Liaw, Bobby Chi-Hung
    Oh, William K.
    Tsao, Che-Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [38] The relative velocity of serum PSA predicts prognosis in hormone refractory prostate cancer.
    Vollmer, RT
    Kantoff, PW
    Dawson, NA
    Vogelzang, NJ
    LABORATORY INVESTIGATION, 1999, 79 (01) : 109A - 109A
  • [39] Impact of statin therapy on PSA kinetics during active surveillance of prostate cancer.
    Rogers, William
    Rothschild, Daniel
    Bylund, Jason R.
    Venkatesh, Ramakrishna
    Demos, Jon
    Strup, Stephen E.
    Preston, David
    Crispen, Paul L.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [40] Simulation optimization of PSA-threshold based prostate cancer screening policies
    Underwood, Daniel J.
    Zhang, Jingyu
    Denton, Brian T.
    Shah, Nilay D.
    Inman, Brant A.
    HEALTH CARE MANAGEMENT SCIENCE, 2012, 15 (04) : 293 - 309
12345